ArticleOncotarget2016
Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells.
Yang Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it